Evidence map›Paper›PMID 41892513›Full record

ArticleGels (Basel, Switzerland)2026

Migration and Chondrogenesis of Cells from Minced Nasal Cartilage in Type I Collagen Hydrogel: A Workflow for One-Step Engineering of Injectable Grafts.

Alexander Gensch, Atharva Damle, Orhan Sonsöz, Diana Mock, Martin Haug, Davide Adamo, Ewelina M Bartoszek, Gyözö Lehoczky, Ivan Martin, Andrea Barbero

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexander GenschDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.ORCID 0009-0003-4424-5173
Atharva DamleDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.ORCID 0000-0001-6944-656X
Orhan SonsözDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.ORCID 0009-0003-5351-2069
Diana MockDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.ORCID 0009-0001-0533-8014
Martin HaugPlastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0003-1726-8794
Davide AdamoCenter for Regenerative Medicine "Stefano Ferrari", University of Modena and Reggio Emilia, 41125 Modena, Italy.ORCID 0000-0003-2317-978X
Ewelina M BartoszekDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.ORCID 0000-0001-5153-9258
Gyözö LehoczkyDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.ORCID 0000-0002-4385-7683
Ivan MartinDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.ORCID 0000-0001-6493-0432
Andrea BarberoDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.ORCID 0000-0001-5252-789X

Funding

European Union's Horizon 2020 research and innovation under the Marie Sklodowska-Curie grant agreement 101034412Innovation Focus "Regenerative Surgery" program at the University Hospital Basel
6 · The paper itself

Abstract

Articular cartilage (AC) damage heals poorly and can progress to osteoarthritis. Implantation of AC fragments (Minced Cartilage Implantation, MCI) is a promising one-step repair technique but is constrained by the limited availability of healthy AC. In this study, we evaluated the feasibility of MCI using nasal septal cartilage (NSC) as an alternative source of hyaline tissue with strong regenerative capacity. NSC obtained from rhinoplasties was decontaminated using a novel protocol, minced with or without Poloxamer 188 (P188), embedded in collagen I gel (0.5 mL per sample), and cultured for 42 days in platelet-rich plasma (PRP)-supplemented medium. The decontamination procedure with a combination of antibiotics was effective and did not impair cell viability. Histology of the resulting constructs confirmed robust cellular outgrowth and matrix deposition. Tissues produced from NSC and fragmented with P188 contained more cartilaginous matrix than those from NSC fragmented without P188 and those from AC fragmented with P188. NSC fragments embedded in a 1 mL hydrogel, sufficient for clinically relevant defect volumes, also demonstrated strong outgrowth and satisfactory matrix formation. Overall, the developed protocol supports the use of NSC as a viable tissue source in gel-based, injectable MCI grafts for focal cartilage repair.

Indexed as

cartilage repairminced cartilagenasal chondrocytes

Identifiers

PMID41892513
PMCPMC13025651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.